Cargando…
Influenza viruses – antiviral therapy and resistance
Influenza is a serious and frequently underestimated, but vaccine preventable disease. The adamantane derivates rimantadine and amantadine and the neuraminidase inhibitors zanamivir and oseltamivir are the only antiviral drugs currently approved in Europe for therapy and prophylaxis of influenza inf...
Autor principal: | Duwe, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301739/ https://www.ncbi.nlm.nih.gov/pubmed/30671326 http://dx.doi.org/10.3205/id000030 |
Ejemplares similares
-
Preparing for the Next Influenza Season: Monitoring the Emergence and Spread of Antiviral Resistance
por: Oh, Djin-Ye, et al.
Publicado: (2023) -
Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations
por: Duwe, Susanne C., et al.
Publicado: (2021) -
Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects
por: van der Vries, Erhard, et al.
Publicado: (2016) -
Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects
por: Hayden, Frederick G.
Publicado: (2009) -
Influenza and antiviral resistance: an overview
por: Lampejo, Temi
Publicado: (2020)